Status:
UNKNOWN
PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Tuberculosis
Eligibility:
All Genders
3-15 years
Brief Summary
To investigate the size of PPD and TB specific ELISPOT among children between 3m/o and 15 y/o . Calculate the normal range of age specific PPD size in children who recieved BCG at new-born period.
Detailed Description
Sampling 1. Age under 3 year-old: a targeted population contains 500 children will be used for sampling of this group. This cohort were firstly enrolled for a trial of oral Rota vaccine since 2004. T...
Eligibility Criteria
Inclusion
- A healthy child with the age between 3 month to 15 year, who has received BCG in the first month of life as schedule, without history of exposure of tuberculosis. -
Exclusion
- Children not received his BCG within one month after birth, immunodeficiency, received steroid or immunosuppresant within 6 weeks, severe infection within 6 weeks, received life vaccine within 6 weeks
- \-
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2005
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT00172783
Start Date
June 1 2005
End Date
December 1 2005
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100